Katya Smirnyagina

 

Dr Katya Smirnyagina has served on the Board of Directors for iSTAR Medical since 2013. She is a Senior Partner with Oxford Science Enterprises, which she joined in 2021 following almost 20 years in venture capital with Capricorn Partners and Alta Partners.

 

Her current and past board memberships include Adocia, Confo Therapeutics, HalioDx, Nexstim, Ablynx, Cerenis Therapeutics, Innate Pharma and Kiadis Pharma. Katya obtained a PhD in Cellular & Molecular Biology from the University of Wisconsin-Madison in Wisconsin, USA which she completed with a Postdoctoral training in Microbiology & Immunology from the Stanford University School of Medicine in California (USA).

scroll to up
Sign up to receive company news alerts